𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Is interleukin-1 a good or bad ‘guy’ in tumor immunobiology and immunotherapy?

✍ Scribed by Ron N. Apte; Elena Voronov

Book ID
111756448
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
394 KB
Volume
222
Category
Article
ISSN
0105-2896

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Good and bad IRF-1: Role in tumor suppre
Good and bad IRF-1: Role in tumor suppression versus autoimmune disease
✍ Dan A. Liebermann; Barbara Hoffman 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 94 KB

## Role in tumor suppression versus autoimmune disease Interferon regulatory factor-1 (IRF-1) is the founder member in a family of transcriptional activators of the interferon-b (IFNb) gene. IRF-1 plays a role in terminal differentiation of hematopoietic cells and in the transcriptional activation

A new model of active specific immunothe
A new model of active specific immunotherapy using interleukin-1 and sonicated tumor supernatant in murine tumor system
✍ Moriguchi, Yoshio; Kan, Norimichi; Okino, Takashi; Harada, Takehisa; Yamasaki, S 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 716 KB

The possibility of active specific immunotherapy using interleukin-1 (IL-1) plus sonicated tumor supernatant (SS) was examined in a murine tumor model. The growth of intraperitoneally or subcutaneously inoculated plasmacytoma MOPC IME, which is syngeneic to BALB/c mice, was significantly suppressed